Cytogenetic findings in untreated patients with essential thrombocythemia

In Vivo

Volumn 20, Issue 3, 2006, Pages 381-384

  Panani, Anna D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromosome abnormalities; Cytogenetics; Essential thrombocythemia; G banding technique

Indexed keywords

CYTOTOXIC AGENT;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION 5; CHROMOSOME IDENTIFICATION; CLINICAL FEATURE; CYTOGENETICS; GENE DELETION; GENE IDENTIFICATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MARKER CHROMOSOME; MONOSOMY; MONOSOMY 14; MONOSOMY 17; RISK ASSESSMENT; THROMBOCYTHEMIA; THROMBOCYTOSIS; TRISOMY; TRISOMY 13; TRISOMY 20;

EID: 33646830088     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bench AJ, Cross NCP, Huntly BJP, Nacheva EP and Green AR: Myeloproliferative disorders. Best Pract Res Clin Haematol 14: 531-551, 2001.
2. Chen Z and Sandberg AA: Molecular cytogenetic aspects of hematological malignancies:clinical implications. Am J Med Genet (Semin Med Genet) 115: 130-141, 2002.
3. Bench AJ and Pahl HL: Chromosomal abnormalities and molecular markers in myeloproliferative disorders. Semin Hematol 42: 196-205, 2005.
4. Hirose Y, Masaki Y and Sugai S: Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases. Eur J Haematol 68: 112-116, 2002.
5. Paolini R, Bonaldi L, Bianchini E, Ramazzina E and Cella G: Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukemia with trisomy 8, trisomy 21 and cutaneous involvement. Eur J Haematol 71: 466-469, 2003.
6. Rise L and Popat U: Every case of essential thrombocythemia should be tested for the Philadelphia chromosome. Am J Hematol 78: 71-73, 2005.
7. Wong KF: A novel interstial deletion of 3p in essential thrombocythemia. Cancer Genet Cytogenet 153: 84-85, 2004.
8. Vardiman JW, Pierre R, Thiele J, Imbert M, Brunning RD and Flandrin G: Chronic myelogenous leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.). Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press, pp. 20-26, 2001.
9. Mitelman F (ed.): (ISCN 1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
10. Uozumi K, Ohno N, Shimotakahara S, Suzuki S, Takeuchi S, Hanada S and Arima T: Trisomy 8 in essential thrombocythemia in leukemic transformation. Cancer Genet Cytogenet 116: 84-86, 2000.
11. Lazarevic VL, Tomin D, Jankovic GM, Antic D, Dencic M, Gotic M and Boskovic D: A novel t(2;17) in transformation of essential thrombocythemia to acute myeloid leukemia. Cancer Genet Cytogenet 148: 77-79, 2004.
12. Munro LR, Stevenson DAJ and Culligan DJ: Translocation (X;5)(q13;q33)in essential thrombocythemia. Cancer Genet Cytogenet 114: 78-79, 1999.
13. Sterkers Y, Preudhomme C, Lai J-L, Demory J-L, Caulier M-T, Wattel E et al: Acute myeloid leukemia and myelodysplastic syndrome following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 91: 616-622, 1998.